The Swedish Medical Products Agency (Läkemedelsverket), and the Ethics committee have approved the Clinical Trial Application of the Phase I, a First in Human study on BioC gel. They study will be run at Lund University Hospital and will include healthy volunteers and treatment of epidermal skin wounds. The aim of the study is to show safety and tolerability.
